March 1, 2011 – The U.S. Court of Appeals for the Federal Circuit has ruled in favor of Hologic and against SenoRX regarding patent infringement involving breast brachytherapy systems.
The court reversed previous decisions reached by the U.S. District Court for the Northern District of California, which were in favor of SenoRx.